Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
3.97%
↓ 90% below average
Average (34q)
40.26%
Historical baseline
Range
High:477.09%
Low:-69.91%
Volatility
1358.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 3.97% |
| Q2 2025 | 19.00% |
| Q1 2025 | 0.03% |
| Q4 2024 | 10.74% |
| Q3 2024 | 12.91% |
| Q2 2024 | 18.28% |
| Q1 2024 | -8.45% |
| Q4 2023 | -8.13% |
| Q3 2023 | 27.13% |
| Q2 2023 | 14.50% |
| Q1 2023 | 0.16% |
| Q4 2022 | 11.50% |
| Q3 2022 | 17.46% |
| Q2 2022 | 14.65% |
| Q1 2022 | 1.86% |
| Q4 2021 | 96.37% |
| Q3 2021 | 23.91% |
| Q2 2021 | 8.68% |
| Q1 2021 | 14.26% |
| Q4 2020 | -24.09% |
| Q3 2020 | 366.11% |
| Q2 2020 | 13.37% |
| Q1 2020 | -4.08% |
| Q4 2019 | 477.09% |
| Q3 2019 | 0.94% |
| Q2 2019 | 29.03% |
| Q1 2019 | -69.04% |
| Q4 2018 | 37.63% |
| Q3 2018 | -28.94% |
| Q2 2018 | 211.41% |
| Q1 2018 | -43.68% |
| Q4 2017 | 174.71% |
| Q3 2017 | -69.91% |
| Q2 2017 | 59.60% |
| Q1 2017 | 0.00% |